CuraDose provides Y-90 SIRT treatment planning as a service - enabling hospitals to offer radioembolization with expert-level dosimetry, without building in-house capacity.
Hospitals submit cases through our secure physician portal. Our expert team handles the rest - from DICOM analysis to personalized treatment plans.
Physicians upload DICOM imaging and clinical data through our secure portal. Automated pseudonymization ensures patient privacy from the moment of upload.
Our dosimetrists create personalized treatment plans using FDA-cleared, CE-approved calculation software - with rigorous quality assurance at every step.
Completed treatment plans are delivered back through the portal with full dosimetry reports - ready for physician review and clinical use.
CuraDose combines decades of experience in interventional oncology, nuclear medicine, and medical device R&D.
Commercial & Clinical Strategy
Former Global Medical Director at a leading medical device company, with extensive experience in interventional oncology market development.
Clinical & Academic Leadership
Professor of Nuclear Medicine at UMC Utrecht, bringing world-class clinical expertise in radioembolization and nuclear medicine.
Platform & Product
Background in radiotherapy (Erasmus MC, Elekta) and medical devices (Global R&D Director). Architect of the CuraDose platform.
Whether you are a hospital looking to start a radioembolization program or a vendor exploring partnership opportunities - we would love to hear from you.